SYSTEMS AND METHODS FOR CHARACTERIZING A BIOLOGICAL CONDITION OR AGENT USING PRECISION GENE EXPRESSION PROFILES
First Claim
Patent Images
1. A method, for evaluating a biological condition of a subject, comprising:
- a. obtaining from the subject a sample having at least one of RNAs and proteins;
b. deriving from the sample a first profile data set, the first profile dataset including a plurality of members, each member being a quantitative measure of the amount of a distinct RNA or protein constituent in a panel of constituents selected so that measurement of the constituents enables measurement of the biological condition; and
c. producing a calibrated profile data set for the panel, wherein each member of the calibrated profile data set is a function of a corresponding member of the first profile data set and a corresponding member of a baseline profile data set for the panel, the calibrated profile data set providing a measure of the biological condition of the subject.
2 Assignments
0 Petitions
Accused Products
Abstract
Methods are provided for evaluating a biological condition of a subject using a calibrated profile data set derived from a data set having a plurality of members, each member being a quantitative measure of the amount of a subject'"'"'s RNA or protein as distinct constituents in a panel of constituents. The biological condition may be a naturally occurring physiological state or may be responsive to treatment of the subject with one or more agents. Calibrated profile data sets may be used as a descriptive record for an agent.
71 Citations
166 Claims
-
1. A method, for evaluating a biological condition of a subject, comprising:
-
a. obtaining from the subject a sample having at least one of RNAs and proteins;
b. deriving from the sample a first profile data set, the first profile dataset including a plurality of members, each member being a quantitative measure of the amount of a distinct RNA or protein constituent in a panel of constituents selected so that measurement of the constituents enables measurement of the biological condition; and
c. producing a calibrated profile data set for the panel, wherein each member of the calibrated profile data set is a function of a corresponding member of the first profile data set and a corresponding member of a baseline profile data set for the panel, the calibrated profile data set providing a measure of the biological condition of the subject. - View Dependent Claims (4, 5, 6, 7, 8, 9, 16, 17, 20, 21, 22, 23, 24, 25, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 53, 54, 55, 56, 58, 59, 69, 70, 71, 76, 107, 108, 109, 110)
-
-
2. A method, for evaluating a biological condition of a subject, comprising:
-
a. obtaining from the subject a first sample having at least one of fluid, cells and active agents;
b. applying the first sample or a portion thereof to a defined population of indicator cells;
c. obtaining from the indicator cells a second sample containing at least one of RNAs or proteins;
d. deriving from the second sample a first profile data set, the first profile data set including a plurality of members, each member being a quantitative measure of the amount of a distinct RNA or protein constituent in a panel of constituents selected so that measurement of the constituents enables measurement of the biological condition; and
e. producing a calibrated profile data set for the panel, wherein each member of the calibrated profile data set is a function of a corresponding member of the first profile data set and a corresponding member of a baseline profile data set for the panel, the calibrated profile data set providing a measure of the biological condition of the subject.
-
-
3. A method, for evaluating a biological condition affected by an agent, the method comprising:
-
a. obtaining, from a target population of cells to which the agent has been administered, a sample having at least one of RNAs and proteins;
b. deriving from the sample a first profile data set, the first profile data set including a plurality of members, each member being a quantitative measure of the amount of a distinct RNA or protein constituent in a panel of constituents selected so that measurement of the constituents enables measurement of the biological condition; and
c. producing a calibrated profile data set for the panel, wherein each member of the calibrated profile data set is a function of a corresponding member of the first profile data set and a corresponding member of a baseline profile data set for the panel, the calibrated profile data set providing a measure of the biological condition as affected by the agent. - View Dependent Claims (10, 11, 12, 13, 14, 15, 18, 19, 26, 27, 46, 47, 48, 49, 50, 51, 52, 57, 60, 61, 62, 63, 64, 65, 128, 131, 132)
-
-
66. A method, for evaluating the effect on a biological condition by a first agent in relation to the effect by a second agent, the method comprising:
-
a. obtaining, from first and second target populations of cells to which the first and second agents have been respectively administered, first and second samples respectively, each sample having at least one of RNAs and proteins;
b. deriving from the first sample a first profile data set and from the second sample a second profile data set, the profile data sets each including a plurality of members, each member being a quantitative measure of the amount of a distinct RNA or protein constituent in a panel of constituents selected so that measurement of the constituents enables measurement of the biological condition; and
c. producing for the panel a first calibrated profile data set and a second profile data set, wherein (i) each member of the first calibrated profile data set is a function of a corresponding member of the first profile data set and a corresponding member of a first baseline profile data set for the panel, and (ii) each member of the second calibrated profile data set is a function of a corresponding member of the second profile data set and a corresponding member of a second baseline profile data set for the panel, the calibrated profile data sets providing a measure of the effect by the first agent on the biological condition in relation to the effect by the second agent. - View Dependent Claims (67, 68)
-
-
72. A method of conducting a clinical trial of an agent, the method comprising:
-
a. causing the blind administration of a selected one of a placebo and the agent to each candidate of a pool of subjects; and
b. using quantitative gene expression to monitor an effect of such administration. - View Dependent Claims (73, 74, 75)
-
-
77. A digital storage medium on which is stored a computer readable calibrated profile data set, wherein:
-
a. the calibrated profile data set relates to a sample having at least one of RNAs and proteins derived from a target cell population to which an agent has been administered; and
b. the calibrated profile data set includes a first plurality of members, each member being a quantitative measure of a change in an amount of a distinct RNA or protein constituent in a panel of constituents selected so that measurement of the constituents enables measurement of a biological condition as affected by administration of the agent. - View Dependent Claims (78, 79, 80, 81, 82, 83, 84, 85, 86, 87)
-
-
88. A digital storage medium on which is stored a plurality of records Ri relating to a population of subjects, each record Ri corresponding to a distinct instance Pi of a computer readable profile data set P wherein:
-
a. each instance Pi of the profile data set P relates to a distinct sample derived from a subject, the sample having at least one of RNAs and proteins;
b. the profile data P set includes a plurality of members Mj, each member Mj being a quantitative measure of the amount of a distinct RNA or protein constituent in a panel of constituents selected so that measurement of the constituents enables measurement of a biological condition;
c. each record Ri includes, for each member Mij of a corresponding distinct instance Pi of the profile data set P, a value corresponding to the value of the member Mij; and
d. each record Ri also includes a reference to a characteristic of the subject relative to the record, the characteristic being at least one of age group, gender, ethnicity, geographic location, diet, medical disorder, clinical indicator, medication, physical activity, body mass, and environmental exposure. - View Dependent Claims (89, 129, 130, 133, 134, 135, 136)
-
-
90. A digital storage medium on is stored a large number of computer readable profile data sets, wherein:
-
a. each profile data set relates to a sample derived from a target cell population to which has been administered an agent, the sample having at least one of RNAs and proteins;
b. each profile data set includes a plurality of members, each member being a quantitative measure of the amount of a distinct RNA or protein constituent in a panel of constituents selected so that measurement of the constituents enables measurement of a biological condition; and
c. the panel is the same for all profile data sets.
-
-
91. A method, for evaluating a biological condition of a subject, based on a sample from the subject, the sample having at least one of RNAs and proteins, the method comprising:
-
a. deriving from the sample a first instance of a profile data set, the profile data set including a plurality of members, each member being a quantitative measure of the amount of a distinct RNA or protein constituent in a panel of constituents selected so that measurement of the constituents enables measurement of the biological condition; and
b. producing a first instance of a calibrated profile data set for the panel, wherein each member of an instance of the calibrated profile data set is a function of a corresponding member of an instance of the profile data set and a corresponding member of an instance of a baseline profile data set for the panel, the calibrated profile data set providing a measure of the biological condition of the subject; and
c. accessing a data in a condition database, the condition database having a plurality of records relating to a population of subjects, each record corresponding to a distinct instance of the calibrated profile data set; and
d. evaluating the first instance of the calibrated profile data set in relation to data in the condition database. - View Dependent Claims (92, 93, 94, 95, 96, 97, 100, 101)
-
-
98. A method of displaying quantitative gene expression analysis data associated with measurement of a biological condition, the method comprising:
-
a. identifying a first profile data set pertinent to the gene expression analysis data, the first profile data set including a plurality of members, each member being a quantitative measure of the amount of a distinct RNA or protein constituent in a panel of constituents selected so that measurement of the constituents enables measurement of the biological condition;
b. producing a calibrated profile data set for the panel, wherein each member of the calibrated profile data set is a function of a corresponding member of the first profile data set and a corresponding member of a baseline profile data set for the panel, the calibrated profile data set providing a measure of the biological condition of the subject; and
c. displaying the calibrated profile data set in a graphical format. - View Dependent Claims (99)
-
-
102. A descriptive record of a change in a biological condition in a population of cells, comprising:
-
a. a first set of numerical gene expression values for a panel of gene loci, each value in the set corresponding to a single gene locus in a panel of gene loci, the set of values forming a profile data set for a population of cells subjected to a first biological condition;
b. a second set of numerical gene expression values for the panel of gene loci, each value in the set corresponding to a single gene locus, the set of values forming a baseline profile data set for a second population of cells subjected to a second biological condition, the second set of values optionally being an average for multiple gene expression values from multiple populations of cells for each locus in the panel; and
c. a third set of numbers corresponding to the ratio of the first set of values and the second set of values with respect to each gene locus in the panel, the third set being a calibrated profile data set;
the profile data set and the calibrated profile data set being descriptive of the first biological condition with respect to the second biological condition. - View Dependent Claims (103, 104, 105, 106, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 137, 138)
-
-
139. A computer program product for evaluating a biological condition of a subject or for evaluating a biological condition resulting from the use of an agent, including a computer usable medium having computer readable program code thereon, the computer program code;
- comprising;
a. a program code for classifying a sample from the subject or the agent for an identifiable record;
b. a program code for deriving a first data set, the first profile data set including a plurality of members, each member being a quantitative measure of the amount of a distinct RNA or protein constituent in a panel of constituents selected so that measurement of the constituents enables measurement of the biological condition;
the profile data set being stored in the record; and
c. a program code for optionally producing a calibrated profile data set for the panel, for storage in the record, each member of the calibrated profile data set being a function of a corresponding member of the first profile data set and a corresponding member of a baseline profile data set for the panel, the calibrated profile data set providing a measure of the biological condition of the subject.
- comprising;
-
140. A computer system for evaluating a biological condition of a subject or for evaluating a biological condition resulting from the use of an agent, the computer system, comprising:
-
a. a classification module for classifying a sample from the subject or the agent in an identifiable record;
b. a derivative module for deriving a first data set, the first profile data set including a plurality of members, each member being a quantitative measure of the amount of a distinct RNA or protein constituent in a panel of constituents selected so that measurement of the constituents enables measurement of the biological condition; and
c. a production module for producing a calibrated profile data set for the panel, wherein each member of the calibrated profile data set is a function of a corresponding member of the first profile data set and a corresponding member of a baseline profile data set for the panel, the calibrated profile data set providing a measure of the biological condition of the subject.
-
-
141. A method for analyzing a patient for a biological condition at a remote site, comprising:
-
a. providing a kit for measuring a profile data base for evaluating a biological condition, the kit including reagents for quantitative analysis of RNA or protein for a panel of gene loci;
b. accessing a centralized database containing baseline profile data sets corresponding to the panel;
c. determining the calibrated profile data set for the patient; and
d. analyzing the biological condition of the patient with respect to a library of calibrated profile data sets.
-
-
142. A method, for evaluating a biological condition of a subject, comprising:
-
d. obtaining from the subject a sample having at least one of RNAs and proteins;
e. deriving from the sample a first profile data set, the first profile dataset including a plurality of members, each member being a quantitative measure of the amount of a distinct RNA or protein constituent in a panel of constituents selected so that measurement of the constituents enables measurement of the biological condition; and
f. producing a calibrated profile data set for the panel, wherein each member of the calibrated profile data set is a function of a corresponding member of the first profile data set and a corresponding member of a baseline profile data set for the panel, the calibrated profile data set providing a measure of the biological condition of the subject;
wherein the biological condition relates to inflammation and the panel includes at least half of the constituents of the Inflammation Precision Panel of Table 1. - View Dependent Claims (143)
-
-
144. A method, for evaluating a biological condition of a subject, comprising:
-
a. obtaining from the subject a sample having at least one of RNAs and proteins;
b. deriving from the sample a first profile data set, the first profile data set including a plurality of members, each member being a quantitative measure of the amount of a distinct RNA or protein constituent in a panel of constituents selected so that measurement of the constituents enables measurement of the biological condition; and
c. producing a calibrated profile data set for the panel, wherein each member of the calibrated profile data set is a function of a corresponding member of the first profile data set and a corresponding member of a baseline profile data set for the panel, the calibrated profile data set providing a measure of the biological condition of the subject;
wherein the biological condition relates to cell growth and differentiation and the panel includes at least half of the constituents of the Cell Growth and Differentiation Precision Panel of Table 2. - View Dependent Claims (145)
-
-
146. A method, for evaluating a biological condition of a subject, comprising:
-
a. obtaining from the subject a sample having at least one of RNAs and proteins;
b. deriving from the sample a first profile data set, the first profile dataset including a plurality of members, each member being a quantitative measure of the amount of a distinct RNA or protein constituent in a panel of constituents selected so that measurement of the constituents enables measurement of the biological condition; and
c. producing a calibrated profile data set for the panel, wherein each member of the calibrated profile data set is a function of a corresponding member of the first profile data set and a corresponding member of a baseline profile data set for the panel, the calibrated profile data set providing a measure of the biological condition of the subject;
wherein the biological condition relates to metabolism and toxicity and the panel includes at least half of the constituents of the Liver Metabolism and Toxicity Precision Panel of Table 3. - View Dependent Claims (147)
-
-
148. A method, for evaluating a biological condition of a subject, comprising:
-
a. obtaining from the subject a sample having at least one of RNAs and proteins;
b. deriving from the sample a first profile data set, the first profile dataset including a plurality of members, each member being a quantitative measure of the amount of a distinct RNA or protein constituent in a panel of constituents selected so that measurement of the constituents enables measurement of the biological condition; and
c. producing a calibrated profile data set for the panel, wherein each member of the calibrated profile data set is a function of a corresponding member of the first profile data set and a corresponding member of a baseline profile data set for the panel, the calibrated profile data set providing a measure of the biological condition of the subject;
wherein the biological condition relates to skin response and the panel includes at least half of the constituents of the Skin Response Precision Panel. - View Dependent Claims (149)
-
-
150. A method, for evaluating a biological condition of a subject, comprising:
-
a. obtaining from the subject a sample having at least one of RNAs and proteins;
b. deriving from the sample a first profile data set, the first profile dataset including a plurality of members, each member being a quantitative measure of the amount of a distinct RNA or protein constituent in a panel of constituents selected so that measurement of the constituents enables measurement of the biological condition; and
c. producing a calibrated profile data set for the panel, wherein each member of the calibrated profile data set is a function of a corresponding member of the first profile data set and a corresponding member of a baseline profile data set for the panel, the calibrated profile data set providing a measure of the biological condition of the subject;
wherein the biological condition relates to the vascular system and the panel includes at least half of the constituents of the Vascular Precision Panel of Table 6. - View Dependent Claims (151)
-
-
152. A method, for evaluating a biological condition of a subject, comprising:
-
a. obtaining from the subject a sample having at least one of RNAs and proteins;
b. deriving from the sample a first profile data set, the first profile dataset including a plurality of members, each member being a quantitative measure of the amount of a distinct RNA or protein constituent in a panel of constituents selected so that measurement of the constituents enables measurement of the biological condition; and
c. producing a calibrated profile data set for the panel, wherein each member of the calibrated profile data set is a function of a corresponding member of the first profile data set and a corresponding member of a baseline profile data set for the panel, the calibrated profile data set providing a measure of the biological condition of the subject;
wherein the biological condition relates to the prostate health and disease and the panel includes at least half of the constituents of the Prostate Precision Panel of Table 5. - View Dependent Claims (153, 155)
-
-
154. A method, for evaluating a biological condition of a subject, comprising:
-
a. obtaining from the subject a sample having at least one of RNAs and proteins;
b. deriving from the sample a first profile data set, the first profile dataset including a plurality of members, each member being a quantitative measure of the amount of a distinct RNA or protein constituent in a panel of constituents selected so that measurement of the constituents enables measurement of the biological condition; and
c. producing a calibrated profile data set for the panel, wherein each member of the calibrated profile data set is a function of a corresponding member of the first profile data set and a corresponding member of a baseline profile data set for the panel, the calibrated profile data set providing a measure of the biological condition of the subject;
wherein the biological condition relates to the prostate health and disease and the panel includes at least half of the constituents of the Prostate Precision Panel of Table 7.
-
-
156. A method, for evaluating a biological condition of a subject, comprising:
-
a. obtaining from the subject a sample having at least one of RNAs and proteins;
b. deriving from the sample a profile data set, the profile dataset including a plurality of members, each member being a quantitative measure of the amount of a distinct RNA or protein constituent in a panel of constituents selected so that measurement of the constituents enables measurement of the biological condition;
wherein such measure is performed for each constituent under conditions wherein efficiencies of amplification for all constituents are substantially similar, the profile data set providing a measure of the biological condition of the subject. - View Dependent Claims (157, 162, 163)
-
-
158. A method, for evaluating a biological condition of a subject, comprising:
-
a. obtaining from the subject a first sample having at least one of fluid, cells and active agents;
b. applying the first sample or a portion thereof to a defined population of indicator cells;
c. obtaining from the indicator cells a second sample containing at least one of RNAs or proteins;
d. deriving from the second sample a profile data set, the profile data set including a plurality of members, each member being a quantitative measure of the amount of a distinct RNA or protein constituent in a panel of constituents selected so that measurement of the constituents enables measurement of the biological condition;
wherein such measure is performed for each constituent under conditions wherein efficiencies of amplification for all constituents are substantially similar, the profile data set providing a measure of the biological condition of the subject. - View Dependent Claims (159)
-
-
160. A method, for evaluating a biological condition affected by an agent, the method comprising:
-
a. obtaining, from a target population of cells to which the agent has been administered, a sample having at least one of RNAs and proteins;
b. deriving from the sample a profile data set, the profile data set including a plurality of members, each member being a quantitative measure of the amount of a distinct RNA or protein constituent in a panel of constituents selected so that measurement of the constituents enables measurement of the biological condition;
wherein such measure is performed for each constituent under conditions wherein efficiencies of amplification for all constituents are substantially similar, the profile data set providing a measure of the biological condition as affected by the agent. - View Dependent Claims (161)
-
- 164. A kit of primer-probe combinations for measuring expression products of at least four constituents selected from any one of Tables 1 through 7.
Specification